CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 144 enrolled
Drug / intervention
Slow tempo musicother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT07196098
NCT07196098N/ACompleted

Effect of Slow Tempo Music on Anxiety Markers During Intravitreal Injection: A Randomised Controlled Trial

Ng Yu Siang·interventional·Posted Sep 29, 2025·Updated Sep 29, 2025

In Brief

A clinical study evaluating Slow tempo music for Pain and Anxiety. Completed, enrolled 144 participants across 1 site.

Detailed Summary

The goal of this clinical trial was to investigate the effects of slow tempo music on anxiety and perceived pain in patients undergoing elective intravitreal injections (IVI). The main questions it aimed to answer were: Did slow tempo music reduce the anxiety and pain of patients undergoing IVI? Did the pain threshold differ among patients of different ethnic groups? Participants were divided into a music intervention group and a control group. Participants in the music group listened to slow tempo music before and during IVI, while participants in the control group received IVI without background music. The study compared salivary alpha-amylase (sAA) levels-an enzyme that correlates with anxiety level-along with blood pressure (BP) and heart rate (HR) of participants before and after IVI. At the end of the treatment, participants' pain scores were obtained.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain, Anxiety
CountriesMalaysia
Collaborators--

Timeline

N/ACompletedFinished
20252026
First PostedSep 29, 2025
Enrollment StartJan 10, 2025
Primary CompletionMar 28, 2025
Study CompletionAug 14, 2025
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 9 months ago

Interventions

Slow tempo musicother

Slow tempo music will be played 15 minutes before and during intravitreal injection.